Assessing the impact of a vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepalese children: a protocol for a phase III, randomized control trial
<p><strong>Background </strong>Enteric fever is estimated to affect 11–20 million people worldwide each year. Morbidity and mortality from enteric fever primarily occur in lower-income countries, with children under 5 years of age experiencing a significant portion of the burden. O...
Hlavní autoři: | Theiss-Nyland, K, Shakya, M, Colin-Jones, R, Voysey, M, Smith, N, Karkey, A, Dongol, S, Pant, D, Farooq, Y, Neuzil, K, Shrestha, S, Basnyat, B, Pollard, A |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Oxford University Press
2019
|
Podobné jednotky
-
Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
Autor: Shakya, M, a další
Vydáno: (2019) -
Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
Autor: Shakya, M, a další
Vydáno: (2019) -
Logistics of implementing a large-scale typhoid vaccine trial in Kathmandu, Nepal
Autor: Colin-Jones, R, a další
Vydáno: (2019) -
Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt
Autor: Dahal, A, a další
Vydáno: (2022) -
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age
Autor: Bijukchhe, SM, a další
Vydáno: (2024)